The medical imaging operator plans to sell 25m shares at $17 to $20 each as private equity firms accelerate long-delayed exit plans amid stronger equity markets and falling interest rates. First-time listings saw their busiest autumn in four years before political gridlock in Washington paused activity. Lumexa runs 184 outpatient centres across 13 states, offering MRI and CT diagnostic services. Its IPO comes as AI-driven imaging tools gain traction, promising greater accuracy, lower costs, and wider patient access. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
